Related Experiment Videos
Obstructive sleep apnea in infants and its management with nasal continuous positive airway pressure
1David Read Laboratory, Department of Medicine, University of Sydney, NSW, Australia. fam@med.usyd.edu.au
Insights
Nasal continuous positive airway pressure (nCPAP) effectively treats obstructive sleep apnea (OSA) in infants, even in a home setting. Long-term use shows effectiveness, but requires regular monitoring due to changing pressure needs as infants grow.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Neonatology
Background:
- Obstructive sleep apnea (OSA) is a significant concern in infants, impacting their health and development.
- Nasal continuous positive airway pressure (nCPAP) is a common treatment for OSA in adults and children.
- The effectiveness of long-term nCPAP therapy for OSA specifically in infants requires further investigation.
Purpose of the Study:
- To evaluate the long-term efficacy of nCPAP in treating obstructive sleep apnea (OSA) in infants.
- To assess the feasibility and outcomes of home-based nCPAP therapy for pediatric OSA.
- To determine the evolving CPAP pressure requirements in infants as they grow.
Main Methods:
- Twenty-four infants diagnosed with OSA were treated using nCPAP delivered via a nasal mask.
- Overnight polysomnography was employed to quantify OSA severity and establish optimal CPAP levels.
- Follow-up polysomnography studies were conducted to monitor OSA progression and ongoing CPAP necessity.
Main Results:
- nCPAP at pressures of 4-6 cm H2O successfully resolved obstructive events and associated sleep disturbances in infants.
- Eighteen infants received home nCPAP therapy for durations ranging from one month to over four years.
- CPAP was discontinued in 13 infants as their OSA resolved; five with anatomical abnormalities continue therapy, with some requiring up to 10 cm H2O.
Conclusions:
- nCPAP is a highly effective treatment modality for managing obstructive sleep apnea in infants.
- Home-based nCPAP therapy is a viable and effective option for pediatric OSA management.
- Continuous monitoring and adjustment of nCPAP pressure are crucial due to developmental changes in infants.
Study Objectives:
Nasal continuous positive airway pressure (nCPAP) is the most common treatment for obstructive sleep apnea (OSA) in adults, and it has been effective in the treatment of OSA in children. We wanted to determine the effectiveness of long-term nCPAP therapy for OSA in infants.
Patients:
Twenty-four infants who had OSA were treated with nCPAP via nose mask. These infants had clinical histories that included a family history of sudden infant death syndrome, an apparent life-threatening event, or facial and upper airway anatomic abnormalities.
Interventions:
Overnight polysomnographic studies were performed to assess the severity of OSA in each infant and to determine the appropriate level of continuous positive airway pressure (CPAP). Studies were repeated to determine the progress of OSA and the continuing need for CPAP in each infant.
Results:
nCPAP pressures between 4 and 6 cm H2O prevented obstruction and reversed sleep disturbances that were associated with OSA. Eighteen of the infants continued treatment at home from 1 month to > 4 years. CPAP therapy was discontinued in 13 infants after their OSA resolved. Five infants who have upper airway anatomic abnormalities remain on CPAP, and the pressure level required to prevent obstructive events during sleep has needed to be increased to as high as 10 cm H2O.
Conclusions:
nCPAP is an effective therapy for the management of OSA in infants, and it can be used effectively in the home environment. Regular follow-up is necessary, because the requirements for CPAP and pressure levels change with the infant's growth and development.